Dosage protocol · Bioregulators

Livagen 20 mg

Typical daily range: 0.5–2.0 mg once daily (gradual titration over 8–12 weeks).

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
  • Typical daily range: 0.5–2.0 mg once daily (gradual titration over 8–12 weeks).
  • Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0667 mg (66.7 mcg) on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
BAC water3.0mL
Concentration6.67mg/mL

Reconstitution

Livagen dosage chart

Livagen dosage chart
20 mgFor research & educational use only.
WeekDoseDraw
Weeks 1–20.5 mg500 mcg 7.5 units0.075 mL
Weeks 3–41.0 mg1000 mcg 15 units0.15 mL
Weeks 5–61.5 mg1500 mcg 22.5 units0.225 mL
Weeks 7–122.0 mg2000 mcg 30 units0.30 mL

How much to draw

The Draw column shows exactly where to stop on a U-100 insulin syringe. Different vial size or dose? The calculator below recomputes it live.

Supplies needed

Supplies needed

Peptide vial

The lyophilized compound

Bacteriostatic water

For reconstitution

U-100 insulin syringes

One per injection

Alcohol swabs

Stopper + site each time

How it works

Livagen is a synthetic tetrapeptide built from four amino acids — lysine, glutamic acid, aspartic acid, and alanine — often abbreviated KEDA and listed in PubChem as H-Lys-Glu-Asp-Ala-OH.[1] It belongs to a category researchers call peptide bioregulators: short peptides studied mainly in Russian and Eastern European laboratories for possible effects on gene activity and cellular aging.

Livagen is not an approved medicine, a hormone, or a growth-factor drug. It is best understood as a laboratory research compound with a fairly narrow, specialized literature centered on chromatin biology, immune cells, and a handful of organ-culture studies.

Benefits & side effects

Livagen's evidence base is built almost entirely from laboratory and ex vivo work rather than patient trials. Key studies include chromatin decondensation and ribosomal gene activation in lymphocytes taken from older adults, ranging from age 75 to 88 in one study.[2][3] A separate human-serum assay found that Livagen inhibited enkephalin-degrading enzymes with an IC50 of about 20 micromolar, while showing no measurable binding to opioid receptors in rat brain tissue.[7]

Additional findings come from rat hepatocyte cultures examining protein-synthesis rhythms and a rat study of oral Livagen affecting digestive-enzyme activity differently in young versus old animals.[8][10] These are informative laboratory and animal results, not evidence of benefit in humans. No randomized controlled human trial measuring patient-level outcomes — symptoms, organ function, survival, or quality of life — appears in the literature reviewed for Livagen.

Calculator

Plan your own dose

Reconstituting a different vial size or targeting a different dose? Run the numbers.

1

Reconstitution

mg
mL
Concentration
Per unit (0.01 mL)
Per 10 units (0.1 mL)
2

Your dose

Doses per vial
Vial lasts
Draw to units =